Healthcare >> CEO Interviews >> November 24, 2003


RAPHAEL J. MANNINO is Executive Vice President, Chief Scientific Officer and a Founder of BioDelivery Sciences International, Inc. and has served as a member of the Board of Directors since the incorporation of BDS in 1995. Dr. Mannino is a world leader in cochleate technology and an internationally recognized expert in applying artificial lipid-based delivery systems to problems in biotechnology, including drug delivery, vaccine design and gene therapy applications. Dr. Mannino's contributions to this field have resulted in numerous peer reviewed publications, book chapters, presentations at national and international symposia, and 11 US patents. Dr. Mannino received his doctoral training in Biological Chemistry from the Johns Hopkins University, School of Medicine, and held faculty positions at UMDNJ, New Jersey Medical School and The Albany Medical College. Profile
TWST: Would you give us a quick overview of your technology as well as

an overview of BioDelivery Sciences International's products?

Dr. Mannino: Fundamentally, BioDelivery Sciences is working

Pin It on Pinterest

Share This